Skip to main content

Table 1 Baseline and treatment characteristics for the entire study cohort and per hemoglobin-to-platelet ratio status

From: The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy

Characteristic

All patients

(N = 193)

HPR ≤ 0.48

(N = 60)

HPR > 0.48

(N = 133)

P-value

Median age, years (range)

54 (18–76)

53 (18–76)

55 (21–75)

0.94

Age group, N (%)

≤ 54

> 54

87 (45.1)

106 (54.9)

30 (50.0)

30 (50.0)

57 (42.9)

76 (57.1)

0.34

Gender, N (%)

Male

Female

138 (71.5)

55 (28.5)

38 (63.3)

22 (36.7)

100 (75.2)

33 (24.8)

0.12

Smoking status, N (%)

Yes

No

178 (92.2)

11 (7.8)

56 (93.3)

4 (6.7)

126 (94.7)

7 (5.3)

0.91

Alcohol consumption, N (%)

Yes

No

159 (82.4)

34 (17.6)

47 (78.3)

13 (21.7)

112 (84.2)

21 (15.8)

0.26

Periodic dental management, N (%)

Absent

Present

0 (0.0)

193 (100.0)

0 (0.0)

60 (100.0)

0 (0.0)

133 (100.0)

1.0

Median pre-C-CRT tooth extraction, N (%)

3 (1–11)

4 (1–11)

3 (1–7)

0.72

Pre-C-CRT tooth extraction group, N (%)

≥ 5

< 5

70 (43.0)

123 (57.0)

27 (45.0)

33 (55.0)

26 (19.5)

107 (80.5)

< 0.001

Median tooth extraction time to C-CRT, days

17 (12–27)

16 (12–26)

18 (13–27)

0.69

T-stage group, N (%)

1–2

3–4

48 (24.9)

145 (75.1)

16 (26.9)

44 (73.1)

32 (24.0)

101 (76.0)

0.63

 N-stage, N (%)

0–1

2–3

37 (19.2)

156 (80.8)

12 (20.0)

48 (80.0)

25 (18.8)

108 (81.2)

0.84

  1. Abbreviations: C-CRT concurrent chemoradiotherapy, HPR hemoglobin-to-platelet ratio, N node, T tumor